A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Autor:	Ing S Tiong, Devendra Hiwase, Emad Uddin Abro, Ashish Bajel, Emma Palfreyman, Sun Loo, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Adam Ivey, Andrew H Wei
Rok vydání:	2022
Předmět:	Immunology Cell Biology Hematology Biochemistry
Zdroj:	Blood. 140:1453-1455
ISSN:	1528-0020 0006-4971
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e0b4915a15574ecf2006bd1ff8d4ad9c https://doi.org/10.1182/blood-2022-163041 Zobrazit plný text záznamu